GL1X · GenesisL1 explorer

Research workbench

Crystal structure of gsk-3B in complex with pyrazine inhibitor C50

Analyse Crystal structure of gsk-3B in complex with pyrazine inhibitor C50 in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6HK7
Type
protein
Length
347 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Glycogen synthase kinase-3 beta
EC
2.7.11.26, 2.7.11.1
UniProt
P49841
Ligands
G8N
Pockets
4 · best druggability 0.64

Structure

x-ray diffraction · 1 distinct chain · 31% helix, 20% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AGlycogen synthase kinase-3 beta (EC 2.7.11.26, 2.7.11.1)protein34731% helix, 20% strandP49841

Ligands and binding sites

  • G8N · 3-azanyl-~{N}-(2-methoxyethyl)-6-[4-(4-methylpiperazin-1-yl)sulfonylphenyl]pyrazine-2-carboxamide · ligand · chains A
  • GOL · Glycerol · additive · chains A
  • DMS · Dimethyl sulfoxide · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12370.640.8227DMS, G8N
2530.590.9124empty
31230.420.7518empty
4650.300.7419empty

Modifications

Observed in the structure: 1 modified (phosphorylation).

Compared structures

  • 6HK7 · Crystal structure of GSK-3B in complex with pyrazine inhibitor C50 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.